[
  {
    "ts": null,
    "headline": "Medtronic (NYSE:MDT) Gains FDA Approval for Advanced Insulin Sensor in 2025",
    "summary": "Medtronic (NYSE:MDT) recently announced the FDA approval for its Simplera Sync sensor, enhancing the MiniMed 780G system with significant technological advancements. Over the past week, Medtronic's share price remained flat, moving in line with broader market trends, which saw a 1.1% decline. Despite the positive product-related news, the share price was likely influenced by market dynamics, as the overall market context played a substantial role in Medtronic's performance. While the...",
    "url": "https://finnhub.io/api/news?id=63c0eb3ee9a5e2521c34de00a70896240b74cea404f64d79a9925972a87f983e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745082707,
      "headline": "Medtronic (NYSE:MDT) Gains FDA Approval for Advanced Insulin Sensor in 2025",
      "id": 133983445,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (NYSE:MDT) recently announced the FDA approval for its Simplera Sync sensor, enhancing the MiniMed 780G system with significant technological advancements. Over the past week, Medtronic's share price remained flat, moving in line with broader market trends, which saw a 1.1% decline. Despite the positive product-related news, the share price was likely influenced by market dynamics, as the overall market context played a substantial role in Medtronic's performance. While the...",
      "url": "https://finnhub.io/api/news?id=63c0eb3ee9a5e2521c34de00a70896240b74cea404f64d79a9925972a87f983e"
    }
  }
]